When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Add Yahoo as a preferred source to see more of our stories on Google. If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, ...

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of ...

Most cancers excel at staying hidden until it’s too late. By the time symptoms appear, the disease often has spread beyond the reach of curative treatment. Ovarian and gastroesophageal cancers are ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe, where a third ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream ...

Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.

May 9 (UPI) --Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early detection ...